Full Text
EE428 Budget Impact of Elranatamab-bcmm in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

Abstract

Authors

B Shah R Sandin Y Liu Y Hu A Schepart D Hughes J Hart P Hlavacek

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×